Subclinical Hypothyroidism in TAFRO Syndrome

OBJECTIVE: TAFRO syndrome is rare, and its underlying mechanisms currently remain unknown. Furthermore, standard therapeutic strategies have yet to be established. One of the hallmarks of TAFRO is pathological hypercytokinemia, which involves vascular endothelial growth factor (VEGF). A correlation...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Satoko, Ono, Kazuo, Nohgawa, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794168/
https://www.ncbi.nlm.nih.gov/pubmed/31178506
http://dx.doi.org/10.2169/internalmedicine.2717-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794168/
https://www.ncbi.nlm.nih.gov/pubmed/31178506
http://dx.doi.org/10.2169/internalmedicine.2717-19

Ejemplares similares